Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers.
De Bonis, P., Anile, C., Pompucci, A., Fiorentino, A., Balducci, M., Chiesa, S., Maira, G., Mangiola, A., Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma, <<ACTA NEUROCHIRURGICA>>, 2012; 154 (8): 1371-1378. [doi:10.1007/s00701-012-1413-2] [http://hdl.handle.net/10807/29590]
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma
De Bonis, Pasquale;Anile, Carmelo;Pompucci, Angelo;Fiorentino, Alba;Balducci, Mario;Chiesa, Silvia;Maira, Giulio;Mangiola, Annunziato
2012
Abstract
Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
